Our results demonstrated that BCC shows dramatically increased mRNA levels of GLI1, GLI2, PTCH1, PTCH2, and SHH. Among these 5 molecules, only GLI1 showed elevated protein expression in BCCs, suggesting a possible role as a diagnostic marker for differentiating BCCs from other skin malignancies. Here, PTCH2 is linked to skin basal cell carcinoma.